Delete search term

To content

Main navigation

Zurich University
of Applied Sciences

Service navigation

PERISINK – Control of the Peripheral sink and thus serum half-life of biologics via harnessing glycan-specific internalisation

Description

This project will be carried out in collaboration with InCephalo, a preclinical-stage biotech company developing innovative therapies for CNS diseases. It focuses on further advancing the companies' proprietary C-Lock platform, mediating prolonged retention of therapeutic molecules within the CNS compartment. We will here develop glycan-optimized variants of biologics, enabling tunable systemic half-life without compromising activity.

Key data

Deputy Projectlead

Project status

ongoing, started 01/2026

Institute/Centre

Institute of Chemistry and Biotechnology (ICBT)

Funding partner

Innosuisse Innovationsprojekt

Privacy Settings

Here we show you which services may run on our website. You decide for yourself which services we may use. You can find more information in our privacy notice.

Our website needs these cookies so that everything works properly. These cookies are created automatically when you are active on the site – for example, when you change privacy settings or fill in forms. You can block these cookies in your browser or set it to warn you about them, but some parts of the website will then no longer display correctly. These cookies do not store any of your personal data.

These services allow us to see how our website is used, but we do not know who you are. By activating these services, you help us make the website better for everyone.